HVTN 078

Safety of and Immune Response to Prime/Boost Vaccine Regimens in Healthy, HIV-1 Uninfected, Ad5 Seronegative Adults

Trial Details:

Ib Completed
National Institute of Allergy and Infectious Diseases (NIAID), HIV Vaccine Trials Network (HVTN) , EuroVacc October 01, 2009
NYVAC-B,VRC-HIVADV038-00-VP Pox env, gag, pol, nef B; Ad 5 Env B
NYVAC-B Viral Vector - Pox
VRC-HIVADV038-00-VP Viral Vector - Adeno
Switzerland 80